Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Not yet recruiting × Advanced Malignancies × Midazolam × Clear all

Phase

Status

Not yet recruiting 2

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Advanced Malignancies 2 Opioid-Related Disorders 1 Neoplasms 1 Cancer Pain 1

Interventions

Midazolam 2 repaglinide 1 drospirenone 1 Ethinyl Estradiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07426757 2026-03-12

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

Pfizer

Phase 1 Not yet recruiting

Advanced Malignancies

NCT07340190 2026-01-14

A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies

Novartis

Phase 1 Not yet recruiting

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡